What is the recommended evaluation and treatment approach for provoked secondary vestibular vulvodynia?

Provoked Secondary Vestibular Vulvodynia: Evaluation and Treatment

Direct Recommendation

Multimodal physical therapy is the first-line treatment of choice for provoked secondary vestibular vulvodynia, demonstrating superior efficacy to topical lidocaine with clinically meaningful improvements in pain, sexual function, and quality of life. 1

Evaluation Approach

Essential History Components

• Pain characteristics: Acute recurrent pain at vaginal entry triggered by pressure or attempted penetration 1
• Temporal pattern: Determine if secondary (developed after period of pain-free intercourse) vs primary
• Associated conditions: Screen for bladder pain syndrome, irritable bowel syndrome, endometriosis, fibromyalgia, chronic fatigue syndrome, and autoimmune diseases 2
• Psychosexual impact: Loss of sexual interest, avoidance behaviors, focus on partner satisfaction rather than own pleasure 3
• History of trauma: Physical or sexual abuse (use preformed questionnaires for this sensitive topic) 2

Physical Examination Specifics

• Cotton swab test: Apply pressure to vestibular glands to reproduce pain and map affected areas
• Pelvic floor assessment: Evaluate for trigger point tenderness, superficial/deep vaginal tenderness, and pelvic floor muscle dysfunction 2
• Rule out other pathology: Atrophic changes, vaginitis, dermatosis, vulvar/vestibular disease, prolapse 2
• Assess for complications: Check for introital narrowing that may cause dyspareunia or voiding difficulties 4

Baseline Investigations

• Exclude infections: Urine culture, consider testing for ureaplasma and chlamydia if pyuria present with negative cultures 2
• Rule out candidiasis: Particularly if recurrent symptoms; note that C. glabrata may show azole resistance at vaginal pH 5
• No imaging required: Do not obtain radiographic studies unless additional inconsistent signs/symptoms present 6, 7

Treatment Algorithm

First-Line: Multimodal Physical Therapy (10 weeks)

This is the evidence-based treatment of choice 1:

• Weekly sessions including:
  • Patient education on pain mechanisms
  • Pelvic floor muscle exercises with biofeedback
  • Manual therapy techniques
  • Vaginal dilation training

Expected outcomes 1:

• 79% report being "very much" or "much improved" (vs 39% with lidocaine)
• Mean pain reduction of 1.8 points greater than lidocaine
• Improvements maintained at 6-month follow-up
• Clinically meaningful changes in sexual function and distress

Second-Line Options (if physical therapy unavailable or partially effective)

Psychological interventions 8:

• Cognitive behavioral therapy
• Pain management skills training
• Sexual health education integrated with pain strategies 3

Topical agents (lower efficacy):

• Overnight 5% lidocaine ointment 1, 9
• Note: Physical therapy demonstrates 1.8-point greater pain reduction than lidocaine

Systemic neuromodulators 9:

• Oral desipramine with 5% lidocaine cream (RCT evidence)
• Gabapentin or amitriptyline cream (lower evidence)

Third-Line: Advanced Interventions

Intravaginal therapies 9:

• Diazepam tablets with transcutaneous electrical nerve stimulation (TENS)
• Botulinum toxin type A 50 units (RCT evidence)

Surgical option (last resort after failed conservative treatments):

• Vestibulectomy with success rates 52-93% 10
• Consider only after minimum 6-12 months of failed multimodal therapy
• Bartholin cysts occur in up to 9% post-operatively 10

Critical Management Points

Multidisciplinary Approach Superiority

A hospital-based program integrating psychological skills, pelvic floor physiotherapy, and medical management showed 3:

• 53.8% significant improvement in dyspareunia
• Strong effects for reducing sex-related distress (P < 0.001)
• Improvements in all sexual function domains retained at 3-4 month follow-up

Common Pitfalls to Avoid

1. Misdiagnosis as recurrent vaginitis: Vulvodynia is frequently underdiagnosed and mistaken for infectious causes 9

2. Premature surgical referral: Surgery should only follow failed conservative treatments for 6-12 months 10

3. Inadequate treatment duration: Physical therapy requires full 10-week course for optimal benefit 1

4. Ignoring pelvic floor dysfunction: This is a key treatable component often overlooked 1

5. Overlooking neuropathic pain component: If symptoms persist despite clinical improvement, consider vestibulodynia/vulvodynia as neuropathic pain requiring different management (xylocaine 5% ointment, then amitriptyline if unresponsive) 4

Reassessment Timeline

• Post-treatment evaluation: Within 1 month to document response 6, 7
• If persistent symptoms: Re-evaluate for unresolved pathology or coexisting vestibular/pelvic floor dysfunction 7
• Long-term follow-up: Monitor for recurrence and psychosexual complications 7

Special Considerations

Pregnancy: Only topical azole therapy if concurrent candidiasis; avoid systemic treatments 5

HIV/Immunosuppression: No treatment modifications needed for vulvodynia itself, but increased vigilance for concurrent infections 5

Quality of life impact: Address sexual dysfunction, mental distress, and relationship strain as integral treatment components 3, 9